ABCB1 and squamous cell carcinoma: qRT-PCR tests revealed that gemcitabine triggered a significant increase in ABCB1 and ABCC2 expression both in adeno and squamous cell carcinoma tissues (Fig. 4a, b) while paclitaxel and doxorubicin differentially initiated drug transporter transcription (Fig. 4a, b).